Company Filing History:
Years Active: 2016
Title: The Innovations of Laurent Lessard
Introduction
Laurent Lessard is a notable inventor based in Santa Monica, CA (US). He has made significant contributions to the field of cancer research, particularly through his work on long noncoding RNAs (lncRNAs). His innovative approach has the potential to change the landscape of cancer diagnostics and treatment.
Latest Patents
Laurent Lessard holds a patent titled "Long noncoding RNA (lncRNA) as a biomarker and therapeutic marker in cancer." This patent focuses on the use of lncRNAs as cancer biomarkers and outlines methods for diagnosing, prognosing, and monitoring cancer, including cutaneous melanoma. The methods involve isolating lncRNA transcripts from biological samples, measuring their levels, and comparing these levels to control samples to make informed diagnoses or prognoses. Notably, the lncRNA transcript discussed in the patent includes the linc00340 transcript or its variants, which may also serve as therapeutic targets in cancer treatment. He has 1 patent to his name.
Career Highlights
Laurent Lessard is affiliated with the John Wayne Cancer Institute, where he continues to advance his research in cancer biomarkers and therapeutic strategies. His work is pivotal in bridging the gap between basic research and clinical applications, aiming to improve patient outcomes in cancer care.
Collaborations
Laurent collaborates with esteemed colleagues, including Dave S B Hoon, to further enhance the impact of his research in the field of oncology.
Conclusion
Laurent Lessard's innovative work on long noncoding RNAs represents a significant advancement in cancer research. His contributions have the potential to improve diagnostic and therapeutic approaches, ultimately benefiting patients facing cancer.